IL33 and neoplasm: Interestingly, a current study using humanized mice (NGS mice transplanted with human CD34+ cells and autologous thymus grafts) has demonstrated that co-localization of mast cells and Tregs in IL33+ tumor tissues is significantly associated with resistance to anti-PD1 therapy (166).